Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMETELSTAT vs INAVOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMETELSTAT vs INAVOLISIB: Safety Overview

Metric IMETELSTAT INAVOLISIB
Total FAERS Reports 137 188
Deaths Reported 18 6
Death Rate 13.1% 3.2%
Hospitalizations 37 60
Average Patient Age 77.0 yrs 62.1 yrs
% Female Patients 43.3% 99.4%
FDA Approval Date Jun 6, 2024 Oct 10, 2024
Manufacturer Geron Corporation Genentech, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription